glp-1 medications market 2025 Targeted Peptide Weight Loss Drugs Size to Reach USD 193.44 Billion by 2034 GLP-1 Analogues Market Size, Share

However, not all tested GLP-1RAs have consistently demonstrated reductions in cardiovascular events, and the impact on specific cardiovascular outcomes varied among the effective drugs

Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism

While many studies have highlighted the benefits of antioxidants, there is a need for long-term research to assess their safety and efficacy

Nausea is the single most common side effect of GLP-1 receptor agonist medications and the most common reason patients in clinical trials and in clinic discontinue treatment

h tr iu tr chy mu di nhn

GLP-1 Receptor Agonists and Increased Risk of Tendon Injury in Athletes An increasing number of endurance athletes are taking the fat-suppressing medication